Answers are grounded in this paper and cite their sources.
Schistosomiasis is one of the 20 neglected tropical diseases (NTDs) prioritized by World Health Organization (WHO). It is predominately distributed in subtropical and tropical areas of 78 countries and territories with approximate 800 million people at risk of infection and 241.3 million people requiring preventive chemotherapy (PC) [ 1 ] . Countries are at various stages of control with Africa representing more than 92% of those requiring PC, while Americas and Asia have achieved elimination of schistosomiasis as a public health problem and are moving towards transmission interruption. Due to the increasing available quantity of praziquantel (PZQ) donated by Merck [ 2 ] and other non-profit organizations, the treatment coverage for school-aged children (SAC) raised from 25.9% in 2012 to 66.8% by 2019 but declined significantly due to the COVID-19 pandemic [ 1 , 3 ]. Expansion of PC combined with other interventions resulted in a significant reduction of the prevalence of schistosomiasis including the Africa where 60% prevalence reduction has been observed [ 4 ].
No takes yet. Share an insight, caveat, or question.
Xu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: